Through
11/26
A new study shows NFL players return to the field quickly and with no dip in their stats, but this may come at a cost.
As the Center for Neuroscience & Society celebrates 10 years, founding director Martha Farah reflects on the array of research from its faculty, on subjects from brain games to aggression.
Researchers find fluorodeoxyglucose (FDG) PET, which measures the brain’s glucose consumption as a marker of neural activity, is a better indicator of cognitive performance when compared to PET scans that detect amyloid proteins.
Aging diminishes the ability of the eyes to focus up close. New Penn research reports that monovision, a common prescription lens correction to mitigate this issue, can cause dramatic misperceptions of depth and 3D direction for objects in motion.
Images reveal key brain differences, particularly in the cerebellum, between impacted patients and healthy individuals, which may underlie clinical findings previously reported by the Penn team.
As cells age, their ability to remove damaged proteins and structures declines, which could be a risk factor for neurodegenerative brain diseases.
Food, alcohol, and certain drugs all act to reduce the activity of hunger neurons and to release reward signals in the brain, but alcohol and drugs rely on a different pathway than does food.
The Penn Memory Center’s Sanjeev Vaishnavi discusses the progress and setbacks made in Alzheimer’s research in the past five years.
The exercise is one part of a two-week mindCORE summer workshop aimed at underrepresented undergrads across the country. This year’s program focused on language science and technology, and minds in the world.
A brain imaging study finds negative implicit biases against individuals with scars, birthmarks, and other facial differences.
A study by Wenqin Lo of the Perelman School of Medicine and colleagues used detailed analyses of the genes used by individual nerve cells to identify 16 distinct types of nerve cells in humans.
FULL STORY →
Penn Medicine resident Noor Shaik and Michael Rubenstein of the Perelman School of Medicine discuss a West Philadelphia clinic that became a model for collaborations between academic health systems and community organizations.
FULL STORY →
Jeffrey Maneval of the Perelman School of Medicine classifies two new drug treatments for Alzheimer’s as “a double, not a home run.”
FULL STORY →
César de la Fuente of the Perelman School of Medicine and School of Engineering and Applied Science says the main pillars that have enabled us to almost double our lifespan in the last 100 years have been antibiotics, vaccines, and clean water.
FULL STORY →
César de la Fuente of the School of Engineering and Applied Science and Perelman School of Medicine is using AI to identify antimicrobial peptides found in modern and extinct humans, as well as other extinct animals.
FULL STORY →
A study by Holly Elser of the Perelman School of Medicine finds that wildfire smoke exposure can significantly increase the risk of dementia.
FULL STORY →